Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-17-000555
Filing Date
2017-01-17
Accepted
2017-01-17 17:15:10
Documents
1
Period of Report
2017-01-06

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2550
  Complete submission text file 0001493152-17-000555.txt   4102
Mailing Address 1775 38TH STREET BOULDER CO 80301
Business Address 1775 38TH STREET BOULDER CO 80301 303-545-5550
Bioptix, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 808 SOLAR ISLE DR FORT LAUDERDALE FL 33301
Business Address
O'Rourke John R. III (Reporting) CIK: 0001694931 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33675 | Film No.: 17531418